thiazoles has been researched along with Duncan Disease in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baldanzi, G; Bertoni, A; Capello, D; Fresu, LG; Gesu, A; Graziani, A; Massarotti, A; Ruffo, E; Snow, AL; Talmon, M; Tron, GC; Varma, KSS; Velnati, S | 1 |
Baldanzi, G; Baldari, CT; Biskup, C; Das, R; Graziani, A; Kapnick, SM; Larsen, SE; Malacarne, V; Nichols, KE; Patrussi, L; Rubio, I; Ruffo, E; Schwartzberg, PL; Snow, AL; Tedrick, P; Verbist, K; Wülfing, C | 1 |
Bhattacharya, DK; Mandal, C; Sinha, D | 1 |
1 trial(s) available for thiazoles and Duncan Disease
Article | Year |
---|---|
A colorimetric assay to evaluate the chemotherapeutic response of children with acute lymphoblastic leukemia (ALL) employing achatininH: a 9-O-acetyl sialic acid binding lectin.
Topics: Acetylation; Child; Child, Preschool; Colorimetry; Coloring Agents; Evaluation Studies as Topic; Female; Humans; Lectins; Lymphoproliferative Disorders; Male; N-Acetylneuraminic Acid; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tetrazolium Salts; Thiazoles; Treatment Outcome | 1999 |
2 other study(ies) available for thiazoles and Duncan Disease
Article | Year |
---|---|
Identification of a novel DGKα inhibitor for XLP-1 therapy by virtual screening.
Topics: Cell Death; Computer Simulation; Diacylglycerol Kinase; Drug Evaluation, Preclinical; Humans; Lymphoproliferative Disorders; Piperidines; Protein Kinase Inhibitors; Pyrimidinones; Quinazolinones; Ritanserin; Thiazoles | 2019 |
Inhibition of diacylglycerol kinase α restores restimulation-induced cell death and reduces immunopathology in XLP-1.
Topics: Animals; CD8-Positive T-Lymphocytes; Cell Death; Cytokines; Diacylglycerol Kinase; Gene Silencing; Humans; Immunological Synapses; Lymphocyte Activation; Lymphocyte Count; Lymphoproliferative Disorders; Membrane Transport Proteins; Mice; Nuclear Receptor Subfamily 4, Group A, Member 1; Protein Kinase C; Protein Kinase Inhibitors; Pyrimidinones; ras Proteins; Signal Transduction; Signaling Lymphocytic Activation Molecule Associated Protein; Thiazoles | 2016 |